No explicit diseases are being investigated, but rather serious adverse health effects that could be caused by an iodine deficiency or a high phthalate concentration in newborns.
Conditions
Interventions
Group 1: The prevalence of phthlate metabolites in the urine of newborns and their mothers is measured. The results of the questionnaire are used to analyse a possible correlation between the use of p
Sponsors
Universitätsklinik für Kinder- und Jugendmedizin der Ruhr-Universität Bochum
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Written consent of the mothers - Age of majority of the mother - No prematurity of the newborn (from the completed 37th week of pregnancy) - Newborns without pre-existing conditions (treatment on the peripheral labour ward, no transfer required) - Inpatient stay
Exclusion criteria
Exclusion criteria: All cases are excluded, - in which the mother does not agree to participate in the study, - where the mother is not of legal age, - where the mother is unable to provide information for linguistic, psychological or somatic reasons, - where the child was born before the 37th week of pregnancy, - where the child is classified by the hospital staff as ill or requiring intensive monitoring (no treatment on the peripheral labour ward).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of positive detection of phthalate metabolites and insufficient iodine supply in the urine of newborns and their mothers | — |
Secondary
| Measure | Time frame |
|---|---|
| -Correlation with adherent maternal iodine suppression -Correlation between phthalates in newborns and their mothers and the use of plasticiser-containing substances in late pregnancy or immediately before birth | — |
Countries
Germany
Contacts
Public ContactThomas Lücke
Universitätsklinik für Kinder- und Jugendmedizin der Ruhr-Universität Bochum
Outcome results
None listed